scholarly journals Stability of regulatory T cells in T helper 2–biased allergic airway diseases

Allergy ◽  
2020 ◽  
Vol 75 (8) ◽  
pp. 1918-1926 ◽  
Author(s):  
Feng Lan ◽  
Nan Zhang ◽  
Claus Bachert ◽  
Luo Zhang
2010 ◽  
Vol 82 (4) ◽  
pp. 698-705 ◽  
Author(s):  
Jenny Mjösberg ◽  
Göran Berg ◽  
Maria C. Jenmalm ◽  
Jan Ernerudh

2019 ◽  
Vol 60 (7) ◽  
pp. 2583 ◽  
Author(s):  
Yousif Subhi ◽  
Marie Krogh Nielsen ◽  
Christopher Rue Molbech ◽  
Akio Oishi ◽  
Amardeep Singh ◽  
...  

2007 ◽  
Vol 204 (2) ◽  
pp. 357-367 ◽  
Author(s):  
Hamida Hammad ◽  
Mirjam Kool ◽  
Thomas Soullié ◽  
Shuh Narumiya ◽  
François Trottein ◽  
...  

Prostaglandins (PGs) can enhance or suppress inflammation by acting on different receptors expressed by hematopoietic and nonhematopoietic cells. Prostaglandin D2 binds to the D prostanoid (DP)1 and DP2 receptor and is seen as a critical mediator of asthma causing vasodilation, bronchoconstriction, and inflammatory cell influx. Here we show that inhalation of a selective DP1 agonist suppresses the cardinal features of asthma by targeting the function of lung dendritic cells (DCs). In mice treated with DP1 agonist or receiving DP1 agonist-treated DCs, there was an increase in Foxp3+ CD4+ regulatory T cells that suppressed inflammation in an interleukin 10–dependent way. These effects of DP1 agonist on DCs were mediated by cyclic AMP–dependent protein kinase A. We furthermore show that activation of DP1 by an endogenous ligand inhibits airway inflammation as chimeric mice with selective hematopoietic loss of DP1 had strongly enhanced airway inflammation and antigen-pulsed DCs lacking DP1 were better at inducing airway T helper 2 responses in the lung. Triggering DP1 on DCs is an important mechanism to induce regulatory T cells and to control the extent of airway inflammation. This pathway could be exploited to design novel treatments for asthma.


2019 ◽  
Vol 4 (39) ◽  
pp. eaay1160 ◽  
Author(s):  
Suzanne M. Bal ◽  
Ralph Stadhouders

T helper 2–skewed regulatory T cells in the skin use GATA3 to suppress local profibrotic type 2 cytokine production. See the related Research Article by Kalekar et al.


2014 ◽  
Vol 44 (12) ◽  
pp. 3596-3604 ◽  
Author(s):  
Bianca Schulze ◽  
Daniel Piehler ◽  
Maria Eschke ◽  
Heiner von Buttlar ◽  
Gabriele Köhler ◽  
...  

Immunity ◽  
2019 ◽  
Vol 50 (2) ◽  
pp. 362-377.e6 ◽  
Author(s):  
Frédéric Van Gool ◽  
Michelle L.T. Nguyen ◽  
Maxwell R. Mumbach ◽  
Ansuman T. Satpathy ◽  
Wendy L. Rosenthal ◽  
...  

Cytokine ◽  
2009 ◽  
Vol 48 (1-2) ◽  
pp. 118
Author(s):  
Laura Pontecorvo ◽  
Eugenio Stabile ◽  
Leopoldo Laricchia-Robbio ◽  
Giuseppe Rosano ◽  
Andrea la Sala

Sign in / Sign up

Export Citation Format

Share Document